Literature DB >> 5559724

[Comparative study of the treatment of pulmonary tuberculosis by a combination of rifampicin and isoniazid administered daily and twice weekly for a year].

G Decroix, B Kreis, C Sors, J Birenbaum, M Le Lirzin, G Canetti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5559724

Source DB:  PubMed          Journal:  Rev Tuberc Pneumol (Paris)        ISSN： 0035-1792


× No keyword cloud information.
  6 in total

Review 1.  Tuberculosis pharmacotherapy: strategies to optimize patient care.

Authors:  Carole D Mitnick; Bryan McGee; Charles A Peloquin
Journal:  Expert Opin Pharmacother       Date:  2009-02       Impact factor: 3.889

2.  Intermittent treatment regimens in pulmonary tuberculosis.

Authors:  M Zierski
Journal:  Lung       Date:  1979       Impact factor: 2.584

Review 3.  New trends in the chemotherapy of tuberculosis--current aspects.

Authors:  M Zierski
Journal:  Pneumonologie       Date:  1974-06-14

4.  Sensitivity to rifampicin: incidence, mechanism, and prevention.

Authors:  J C Pujet; J C Homberg; G Decroix
Journal:  Br Med J       Date:  1974-05-25

5.  Adverse effects of antituberculosis drugs.

Authors:  D J Girling
Journal:  Drugs       Date:  1982 Jan-Feb       Impact factor: 9.546

Review 6.  Treating tuberculosis with high doses of anti-TB drugs: mechanisms and outcomes.

Authors:  Yuhui Xu; Jianan Wu; Sha Liao; Zhaogang Sun
Journal:  Ann Clin Microbiol Antimicrob       Date:  2017-10-03       Impact factor: 3.944
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.